MEI Pharma Inc (MEIP) Stock
MEIP is no longer traded. MEI Pharma was delisted from the Nasdaq in September 2025.
Prices on this page are historical; the last trade was September 10, 2025 at $3.07.
MEI Pharma stock price history
MEIP final trading statistics
- Final close
- $3.07
- Final trading day
- Sep 10, 2025
- Market cap at delisting
- $100.81M
- Shares outstanding
- 32.84M
- Final 52-week range
- $1.46 – $9.00
- Avg. volume (final 3 mo.)
- 1,434,193
- All-time high (split-adj.)
- $11903.46 · Feb 2004
- All-time low (split-adj.)
- $1.86 · Apr 2025
- Return since IPO
- -100.0%
- Beta
- 0.22
- Book value / share
- $2.93
- Price / book
- 1.05
MEI Pharma annual financials
| Fiscal year | Revenue | Net income | Adj. EPS |
|---|---|---|---|
| FY2025 | $0.00 | -$15.9M | — |
| FY2024 | $65.30M | $17.8M | $2.67 |
| FY2023 | $48.82M | -$31.8M | -$3.87 |
| FY2022 | $40.70M | -$54.5M | -$0.35 |
| FY2021 | $25.54M | -$41.3M | -$0.45 |
Last five fiscal years reported before the delisting; fiscal year ending June. Adj. EPS is adjusted (non-GAAP) earnings per share as reported by the company, so it can differ from net income per share and can be positive in a year with a net loss. Source: company filings via EODHD.
About MEI Pharma Inc
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
MEI Pharma stock FAQ
What happened to MEI Pharma stock?
MEI Pharma stock was delisted from the Nasdaq. Its final close was $3.07 on September 10, 2025.
Is MEIP stock still trading?
No. MEIP was delisted from the Nasdaq in September 2025 and no longer trades on a U.S. exchange.
What was the last price of MEIP stock?
MEIP closed at $3.07 on its final trading day, September 10, 2025, for a market value of about $100.81M.
What were MEI Pharma's revenue and earnings in its last full fiscal year?
MEI Pharma reported revenue of $0.00 and net income of -$15.9M in fiscal 2025, its last full year as a public company.
When did MEI Pharma go public?
MEI Pharma Inc stock began trading on December 19, 2003.